Green Thumb Industries Will Benefit From Medical Cannabis Rescheduling

Green Thumb Industries reported strong Q1-2026 results last week with increasing revenue and improved net income. The company will benefit from the rescheduling of medical cannabis in the US. GTBIF stock price is up 35% over the last year.